a Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC , University of Amsterdam , Amsterdam , the Netherlands.
RNA Biol. 2019 Jul;16(7):890-898. doi: 10.1080/15476286.2019.1599259. Epub 2019 Apr 16.
RNA interference (RNAi) can be triggered by synthetic small interfering RNAs (siRNAs) or transgene-expressed short hairpin RNAs (shRNAs). Recent evidence indicates that shRNA molecules, with a relatively short stem and small loop, are processed by Argonaute 2 protein (Ago2). We named these molecules AgoshRNA as Ago2 is involved in both the processing and the subsequent mRNA-silencing reaction. This alternative processing route yields only a single guide strand, which thus avoids potential off-target effects induced by the passenger strand of a regular shRNA. We recently described that the introduction of a 5'-terminal purine (A or G) and a mismatch at the bottom of the hairpin enhances the AgoshRNA activity. The critical 5'-terminal nucleotide (nt) represents the +1 position of the transcriptional promoter, which influences the transcriptional efficiency and initiation accuracy as demonstrated for the H1 RNA polymerase (Pol) III promoter. These findings highlight the necessity of considering Pol III requirements in the design of optimized AgoshRNA cassettes. In this study, we report the design and expression of potent AgoshRNAs by two other popular Pol III promoters: U6 and 7SK, which were recently reported to have a distinct transcription profile compared to the H1 promoter. We propose general rules for the design and expression of potent AgoshRNA molecules using Pol III cassettes, which should augment the application of novel AgoshRNA reagents for basic research and therapeutic purposes.
RNA 干扰 (RNAi) 可以被合成的小干扰 RNA (siRNAs) 或转基因表达的短发夹 RNA (shRNAs) 触发。最近的证据表明,具有相对短茎和小环的 shRNA 分子由 Argonaute 2 蛋白 (Ago2) 加工。我们将这些分子命名为 AgoshRNA,因为 Ago2 参与了加工和随后的 mRNA 沉默反应。这种替代的加工途径只产生一条单链向导,从而避免了常规 shRNA 过客链引起的潜在脱靶效应。我们最近描述了在发夹底部引入 5'-端嘌呤 (A 或 G) 和错配可以增强 AgoshRNA 的活性。关键的 5'-端核苷酸 (nt) 代表转录启动子的+1 位置,正如 H1 RNA 聚合酶 (Pol) III 启动子所证明的那样,这会影响转录效率和起始准确性。这些发现强调了在设计优化的 AgoshRNA 盒时需要考虑 Pol III 要求。在这项研究中,我们报告了使用另外两个流行的 Pol III 启动子 U6 和 7SK 设计和表达有效的 AgoshRNAs 的情况,与 H1 启动子相比,这两个启动子最近被报道具有独特的转录谱。我们提出了使用 Pol III 盒设计和表达有效 AgoshRNA 分子的一般规则,这应该会增加新型 AgoshRNA 试剂在基础研究和治疗目的中的应用。